rss
J Clin Pathol 2009;62:448-454 doi:10.1136/jcp.2008.063859
  • Original article

VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection

  1. K Engels1,
  2. A du Bois2,
  3. P Harter2,
  4. A Fisseler-Eckhoff3,
  5. F Kommoss4,
  6. R Stauber5,
  7. M Kaufmann6,
  8. V Nekljudova7,
  9. S Loibl6,7
  1. 1
    Department of Pathology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
  2. 2
    Department of Gynaecology and Gynaecological Oncology, Dr Horst Schmidt Kliniken, Wiesbaden, Germany
  3. 3
    Department of Pathology and Cytology, Dr Horst Schmidt Kliniken, Wiesbaden, Germany
  4. 4
    Pathological Institute, Mannheim, Germany
  5. 5
    Department of Molecular and Cellular Oncology, J Gutenberg University, Mainz, Germany
  6. 6
    Department of Gynaecology and Obstetrics, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
  7. 7
    Department of Medicine and Research, GBG Forschungs GmbH, Neu-Isenburg, Germany
  1. Dr Knut Engels, Johann Wolfgang Goethe University, Department of Pathology, Theodor-Stern Kai 7, 60590 Frankfurt am Main, Germany; k.engels{at}em.uni-frankfurt.de
  • Accepted 17 December 2008
  • Published Online First 6 January 2009

Abstract

Aims: Clinical stage at the time of diagnosis and achievement of complete macroscopic resection during initial surgery are key factors determining the outcome of ovarian cancer. However, prediction of outcome lacks accuracy and more reliable prognostic factors are required. Therefore, an analysis and evaluation of key angiogenic factors was carried out to determine their diagnostic and prognostic value in serous ovarian cancer.

Methods: Expression levels of vascular endothelial growth factor (VEGF)-A, hypoxia-inducible factor (HIF)1-α and inducible nitric oxide synthase (i-NOS) were analysed by immunohistochemistry in a homogenous group of 112 patients with serous adenocarcinoma of the ovary. Vascular density as an indicator of angiogenesis was assessed using the Chalkley eyepiece method after staining for CD34. The correlation of these data with survival and established prognostic factors such as histological grade, Federation of Gynecology and Obstetrics (FIGO) stage, and residual tumour after surgery, was evaluated. Survival analyses, multivariate analyses and correlation tests were performed.

Results: In the patient group with macroscopic complete tumour resection (R0) there was a significant correlation between VEGF-A and i-NOS expression. Kaplan–Meier analysis further revealed improved progression-free survival for R0 patients with VEGF-A-positive and i-NOS-negative tumours. The predictive relevance of VEGF-A regarding progression-free survival was sustained in multivariate analysis using FIGO stage, grading and resection status as fixed variables.

Conclusion: VEGF-A and i-NOS are prognostic markers for clinical outcome in serous ovarian cancer patients with macroscopic complete tumour resection (R0). Hence, pre-therapeutic assessment of VEGF-A as predictive factor for an antiangiogenic therapy might be of clinical value.

Footnotes

Responses to this article

  • Which is the cart and which the horse?
    • Richard G Fiddian-Green
    J Clin Pathol published online May 8, 2009

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jcp.2008.063859v1
    2. 62/5/448 most recent

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.